MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer.
Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, Withers HG, Hu Q, Liu T, Liu S, Wong KK, Long MD, Kufe D.
Hagiwara M, et al. Among authors: liu s, liu t.
Oncoimmunology. 2022 Feb 1;11(1):2029298. doi: 10.1080/2162402X.2022.2029298. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35127252
Free PMC article.